Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 35Gastrointestinal 31Genitourinary 20Gynecologic 16Head & Neck 13Dermatologic 10Breast 9Lymphoid 4Other solid neoplasm 3Endocrine 2Sarcoma 1NET 1CNS 1

Conditions

Sarcoma 436Osteosarcoma 132Sarcoma, Ewing 89Melanoma 80Rhabdomyosarcoma 77Neoplasms 71Gastrointestinal Stromal Tumors 63Neuroblastoma 62Bone Neoplasms 62Breast Neoplasms 61Ovarian Neoplasms 60Colorectal Neoplasms 60Glioblastoma 55Neoplasm Metastasis 52Liposarcoma 52Dendritic Cell Sarcoma, Interdigitating 45Carcinoma, Non-Small-Cell Lung 43Leiomyosarcoma 42Gliosarcoma 42Stomach Neoplasms 41Pancreatic Neoplasms 41Lymphoma 36Uterine Cervical Neoplasms 35Sarcoma, Synovial 35Carcinoma, Renal Cell 35Rhabdoid Tumor 34Neurofibrosarcoma 34Lung Neoplasms 34Glioma 34Sarcoma, Kaposi 33

Interventions

spartalizumab 1ribociclib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Parkinson Disease 4, Autosomal Dominant Lewy Body × Sarcoma × 1 year × Clear all
NCT04000529 2025-09-30

Phase Ib Study of TNO155 in Combination With Spartalizumab or Ribociclib in Selected Malignancies

Novartis

Phase 1 Terminated
122 enrolled
GastrointestinalHead & NeckSarcomaThoracic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma, Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms, Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡